A Yeast Three Hybrid Assay for Metabolic Engineering of Tetracycline Derivatives
- 29 June 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 57 (31) , 4726-4734
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases (R01 AI110794)
This publication has 60 references indexed in Scilit:
- Perspectives for the use of biotechnology in green chemistry applied to biopolymers, fuels and organic synthesis: from concepts to a critical point of viewSustainable Chemistry and Pharmacy, 2017
- Biosensor-based engineering of biosynthetic pathwaysCurrent Opinion in Biotechnology, 2016
- Development of a platform for the discovery and practical synthesis of new tetracycline antibioticsCurrent Opinion in Chemical Biology, 2016
- Impact of synthetic biology and metabolic engineering on industrial production of fine chemicalsBiotechnology Advances, 2015
- Looking for the pick of the bunch: high-throughput screening of producing microorganisms with biosensorsCurrent Opinion in Biotechnology, 2014
- Transcriptional regulation improves the throughput of three‐hybrid counter selections in Saccharomyces cerevisiaeBiotechnology Journal, 2013
- Two-way Interdomain Signal Transduction in Tetracycline RepressorJournal of Molecular Biology, 2006
- Regioselective synthesis of peptidic derivatives and glycolamidic esters of MethotrexateTetrahedron, 2004
- A simple and efficient procedure for transformation of Schizosaccharomyces pombeYeast, 2004
- Teaching TetR to Recognize a New InducerJournal of Molecular Biology, 2003